Should I buy Equity Residential (EQR) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Equity Residential
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barclays | 0 % | 0.0 % | 10 | $75 +18% |
| UBS | 0 % | 0.0 % | 8 | $73 +15% |
| Mizuho | 0 % | 0.0 % | 11 | $70 +10% |
| Evercore ISI Group | 0 % | 0.0 % | 8 | $72 +13% |
| BMO Capital | 0 % | 0.0 % | 5 | $74 +16% |
| Piper Sandler | 0 % | 0.0 % | 9 | $76 +19% |
| Truist Securities | 0 % | 0.0 % | 8 | $72 +13% |
| RBC Capital | 0 % | 0.0 % | 10 | $70 +10% |
✅ Reasons to believe
- Median price target $70, i.e. +10% from the current price ($64).
- The most reliable firm on EQR, Barclays (0% hit rate, 10 scored calls), targets $75 (call made on September 2, 2026, maturing on September 2, 2027) (+18%) in its most recent call, and $77 (call made on November 25, 2025, maturing on November 25, 2026) (+21%) in the one coming due soonest.
- Pays a dividend (4.1% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 14 ratings, 10 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on EQR
Median target $70 (+10%) · 14 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Equity Residential now?
We won't decide for you. The facts: 29% of analysts rate it a buy, median target $70 (+10%), and Barclays (most reliable on EQR, 0%) targets $75. Weigh that against valuation (P/E ~29). This is not personalized advice.
Is it too late to invest in Equity Residential?
Not according to analysts: the median target ($70) is still +10% above the current price ($64) (most reliable on EQR: Barclays, 0%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Equity Residential still worth investing in?
It depends on the gap between the price ($64) and its estimated value: analysts target $70 on median (+10%), with 29% buys (most reliable on EQR: Barclays, 0%). Cross-check with their real reliability on EQR and the cautions above. Information, not advice.
What's the main risk in buying EQR?
The consensus is not unanimous: of 14 ratings, 10 are neutral.
→ Go deeper: the full Equity Residential profile (consensus, analyst reliability, price target, performance).